Report ID: SQMIG35I2209
Report ID:
SQMIG35I2209 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
89 |
Figures:
76
North America held the greatest market share of 39.30% in 2022; growth in the region may be ascribed to a number of factors, including an elevated prevalence of infectious illnesses, rapid adoption of new and advanced R&D technologies, and the presence of major companies. Furthermore, businesses in the region are concentrating on joint ventures and research partnerships that are expected to fuel market expansion in the future years.
Asia-Pacific is anticipated to expand rapidly from 2022 to 2028, owing to the growth of the pharmaceutical nanotechnology industry and constant software development in the region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2209